Skip to main content
. 2016 Aug 18;11(8):e0158667. doi: 10.1371/journal.pone.0158667

Fig 4. Association between PLAGL2 expression and BCR-free survival and OS of PCa patients assessed by Kaplan–Meier survival curves.

Fig 4

(A) The patients with high expression had significantly shorter median 5-year BCR-free survival than those with low PLAGL2 expression. (B) The patients with high expression had significantly shorter median 5-year OS than those with low PLAGL2 expression.